Lumbosacral radicular pain market to reach $1.28 billion by 2030 at 5.7% CAGR, driven by increasing prevalence of degenerative spinal conditions and rising prevalence of obesity.
Read More
Losartan potassium active pharmaceutical ingredient (api) market to reach $2.54 billion by 2030 at 6.5% CAGR, driven by growing prevalence of hypertension.
Read More
Local anesthesia drugs market to reach $6.15 billion by 2030 at 5.6% CAGR, driven by increase in prevalence of chronic diseases.
Read More
Liver health supplements market to reach $14.82 billion by 2030 at 6.3% CAGR, driven by rising consumption of alcohol and increasing prevalence of chronic liver diseases.
Read More
Liver Cancer Therapeutics Global Forecast: Market to Scale Up to $6.34 Billion by 2030 at 16.5% CAGR
Liver cancer therapeutics market to reach $6.34 billion by 2030 at 16.5% CAGR, driven by rise in incidence of hepatitis b infections.
Read More
Live cell imaging microscopes market to reach $2.5 billion by 2030 at 7.9% CAGR, driven by growing demand for cell-based research.
Read More
Live attenuated vaccines market to reach $41.11 billion by 2030 at 9.6% CAGR, driven by increasing prevalence of infectious diseases.
Read More
The global liraglutide market to reach $10.23 billion by 2030 at 8.3% CAGR, driven by increasing diabetic population.
Read More
Lipid regulators market to reach $10.38 billion by 2030 at 5.9% CAGR, driven by increasing prevalence of cardiovascular diseases.
Read More
Lifestyle-related disease supplements market to reach $91.73 billion by 2030 at 9.5% CAGR, driven by rising awareness of health and wellness.
Read More